Zelalem Eshete

Array ( [id] => 8417676 [patent_doc_number] => 20120245177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-27 [patent_title] => 'CRYSTALLINE LEVOFOLINIC ACID AND PROCESS FOR ITS PREPARATION' [patent_app_type] => utility [patent_app_number] => 13/426021 [patent_app_country] => US [patent_app_date] => 2012-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3363 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13426021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8465879 [patent_doc_number] => 20120271045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'METHODS FOR PREPARING PYRIMIDINE DERIVATIVES USEFUL AS PROTEIN KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/497139 [patent_app_country] => US [patent_app_date] => 2012-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28279 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13497139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8290417 [patent_doc_number] => 20120178739 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-12 [patent_title] => 'LACTAM COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/419663 [patent_app_country] => US [patent_app_date] => 2012-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 70519 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13419663 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9263194 [patent_doc_number] => 20130345123 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-26 [patent_title] => 'SUBSTITUTED ADIPIC ACID AMIDES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/005018 [patent_app_country] => US [patent_app_date] => 2012-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 74013 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14005018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8393110 [patent_doc_number] => 20120230951 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-13 [patent_title] => 'ANTIVIRAL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/414854 [patent_app_country] => US [patent_app_date] => 2012-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 84094 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13414854 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8591993 [patent_doc_number] => 08349869 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-08 [patent_title] => 'Macrocylic inhibitors of hepatitis C virus' [patent_app_type] => utility [patent_app_number] => 13/412997 [patent_app_country] => US [patent_app_date] => 2012-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40195 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13412997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9875357 [patent_doc_number] => 08962623 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-24 [patent_title] => 'Aminopyrazine compounds' [patent_app_type] => utility [patent_app_number] => 14/001936 [patent_app_country] => US [patent_app_date] => 2012-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 72364 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14001936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10601255 [patent_doc_number] => 09321808 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-26 [patent_title] => 'Homo- and heterodimeric SMAC mimetic compounds as apoptosis inducers' [patent_app_type] => utility [patent_app_number] => 14/379675 [patent_app_country] => US [patent_app_date] => 2012-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 24312 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14379675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8416671 [patent_doc_number] => 20120244171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-27 [patent_title] => 'CYTOTOXIC BENZODIAZEPINE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 13/397195 [patent_app_country] => US [patent_app_date] => 2012-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 53 [patent_no_of_words] => 51111 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13397195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8370262 [patent_doc_number] => 20120219641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-30 [patent_title] => '5-HT3 RECEPTOR MODULATORS, METHODS OF MAKING, AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/372967 [patent_app_country] => US [patent_app_date] => 2012-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36332 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13372967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8346910 [patent_doc_number] => 20120207833 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-16 [patent_title] => 'FORMS OF RIFAXIMIN AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/371238 [patent_app_country] => US [patent_app_date] => 2012-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 56 [patent_no_of_words] => 28837 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13371238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8348066 [patent_doc_number] => 20120208996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-16 [patent_title] => 'PROCESS FOR THE SYNTHESIS OF IVABRADINE AND ADDITION SALTS THEREOF WITH A PHARMACEUTICALLY ACCEPTABLE ACID' [patent_app_type] => utility [patent_app_number] => 13/369690 [patent_app_country] => US [patent_app_date] => 2012-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2137 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13369690 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9561976 [patent_doc_number] => 20140179690 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-26 [patent_title] => 'FUSED AMINODIHYDROTHIAZINE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 13/979961 [patent_app_country] => US [patent_app_date] => 2012-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 40403 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13979961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8187185 [patent_doc_number] => 20120116071 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'Rifaximin' [patent_app_type] => utility [patent_app_number] => 13/350623 [patent_app_country] => US [patent_app_date] => 2012-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3635 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20120116071.pdf [firstpage_image] =>[orig_patent_app_number] => 13350623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8301984 [patent_doc_number] => 20120184542 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'PYRIDO PYRIMIDINES' [patent_app_type] => utility [patent_app_number] => 13/348665 [patent_app_country] => US [patent_app_date] => 2012-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 69887 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13348665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9552291 [patent_doc_number] => 08759339 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-24 [patent_title] => 'Pyrrolo[2,1-c][1,4]naphthodiazepine linked piperazine compounds and a process for the preparation thereof' [patent_app_type] => utility [patent_app_number] => 13/985510 [patent_app_country] => US [patent_app_date] => 2012-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 18860 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13985510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10534819 [patent_doc_number] => 09260440 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-16 [patent_title] => 'Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors' [patent_app_type] => utility [patent_app_number] => 14/369374 [patent_app_country] => US [patent_app_date] => 2011-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30175 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14369374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8302181 [patent_doc_number] => 20120184733 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'CATALYST COMPOSITION AND METHOD FOR PREPARING AMIDE USING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/332834 [patent_app_country] => US [patent_app_date] => 2011-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2436 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13332834 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8359638 [patent_doc_number] => 20120214801 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'COMPOSITIONS AND METHODS RELATING TO NOVEL COMPOUNDS AND TARGETS THEREOF' [patent_app_type] => utility [patent_app_number] => 13/327345 [patent_app_country] => US [patent_app_date] => 2011-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23573 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13327345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10083480 [patent_doc_number] => 09120818 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-01 [patent_title] => 'Process and intermediates for preparing macrolactams' [patent_app_type] => utility [patent_app_number] => 13/993541 [patent_app_country] => US [patent_app_date] => 2011-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15090 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13993541 [rel_patent_id] =>[rel_patent_doc_number] =>)